Diarrhea on Ozempic®

Three documents, three pools

Each official document builds its diarrhea figure from a different group of trials. The US table uses two 30-week placebo-controlled studies in adults with type 2 diabetes. Europe uses eight phase 3a trials with 4,792 people on semaglutide up to 1 mg. Canada uses seven controlled trials and compares Ozempic® with a pooled group that mixes placebo and active diabetes medicines ^[1][2][3]. That is why the numbers differ, and why the US placebo figure is not directly comparable with the Canadian comparator figure.

Reading the pattern

Diarrhea on placebo was low in the US trials, so both Ozempic® groups reported it more than four times as often. Raising the dose from 0.5 mg to 1 mg moved the rate very little in all three documents, unlike vomiting, which climbed noticeably with dose ^[1][2][3].

The 2 mg dose is different. In the 40-week trial comparing 1 mg with 2 mg, the European information says diarrhoea and vomiting were reported by a higher share on 2 mg, while stopping because of stomach reactions was similar on the two doses. The US label gives only the overall stomach and bowel figure from that trial: 34% on 2 mg against 30.8% on 1 mg ^[1][2].

When it appears and how severe it was

The US label says most reports of nausea, vomiting and diarrhea occurred during dose escalation, the stretch that starts with four weeks of 0.25 mg and continues through each later increase. Europe says stomach events were mostly mild to moderate, short-lived and most frequent in the first months on treatment ^[1][2].

Severe stomach and bowel reactions of any kind were reported in 0.4% on 0.5 mg and 0.8% on 1 mg in the US trials, with none on placebo; the label does not split out severe diarrhea. Europe and Canada add that people with lower body weight tended to have more stomach side effects ^[1][2][3].

Does metformin make it worse?

Many people on Ozempic® also take metformin, so this question comes up often. A post hoc analysis of four large trials of liraglutide and semaglutide looked at 16,996 participants, 76% of whom used metformin. Metformin use did not increase the share of people who developed stomach side effects while the GLP-1 medicine was being started and raised, nor their severity, nor the rate of stopping among those affected ^[4].

That is reassuring at group level, but it does not describe any one person. If diarrhea started after a change to either medicine, tell your prescriber which one changed and when.

Fluid loss and the kidney warning

For the label, diarrhea matters mostly because of water. Section 5.6 describes acute kidney injury reported after approval in people using semaglutide, sometimes needing hemodialysis, mostly in people whose stomach or bowel reactions had led to dehydration; diarrhea is named alongside nausea and vomiting ^[1]. Section 8.6 says no Ozempic® dose change is needed for kidney impairment as such, so the concern is the fluid loss rather than the kidneys alone ^[1].

NIDDK lists the signs of dehydration in adults as extreme thirst or a dry mouth, passing less urine, feeling tired, dizzy or lightheaded, dark urine, skin that stays tented when pinched, and sunken eyes or cheeks ^[5].

Why it may happen

What the label supports: diarrhea is a recognised reaction that rose clearly above placebo and clustered around dose increases ^[1].

What is not established: none of the three documents explains the mechanism. Semaglutide slows stomach emptying, but that alone would not obviously speed the bowel, so it is safer not to assume a single cause.

General background: NIDDK notes that diarrhea can also come from infections, food intolerances, other medicines and digestive conditions ^[5].

Other possible causes

• Stomach flu and food or water contaminated with bacteria or parasites, the most common causes of short-term diarrhea ^[7].
• Other medicines, such as some antibiotics and laxatives that contain magnesium ^[7].
• Lactose intolerance, coeliac disease, inflammatory bowel disease and irritable bowel syndrome ^[7].
• Recent travel, especially with untreated water ^[7].
• Black stools, blood or pus point away from an ordinary side effect and need prompt attention ^[5][7].

What may help

The Medication Guide and Novo Nordisk’s patient page both stress drinking fluids to lower the chance of dehydration, and following the dose escalation schedule your prescriber sets ^[1][8].

NIDDK suggests replacing lost fluids and electrolytes with water, broths and drinks that contain electrolytes, and says most people can return to their normal diet once appetite comes back. It adds that adults with diabetes or kidney disease should speak to a doctor before drinking oral rehydration solutions, because a specific type or amount may suit them better ^[6].

Over-the-counter antidiarrheal medicines such as loperamide and bismuth subsalicylate are described by NIDDK and MedlinePlus as an option for many adults, but not with fever or bloody stools ^[6][7]. Ask your pharmacist or prescriber before using one alongside Ozempic®.

What a useful log looks like

Clinicians usually want the number of loose stools a day and for how many days, whether there was blood, black colour or fever, how much you drank, and whether it began near an injection or a dose increase. Writing it down as it happens is more reliable than reconstructing it weeks later.

Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help